Go Pro
→ Here’s the stock symbol I’ve promised (From Stansberry Research) (Ad)tc pixel Free IINN Stock Alerts

Inspira Technologies OXY B.H.N. (IINN) Competitors

Inspira Technologies OXY B.H.N. logo
$1.00 -0.01 (-0.99%)
As of 08/13/2026
Compare

IINN vs. CVRX, RCEL, MBOT, KEQU, and HYPR

Should you buy Inspira Technologies OXY B.H.N. stock or one of its competitors? Inspira Technologies OXY B.H.N.'s main competitors and comparable companies include CVRx (CVRX), Avita Medical (RCEL), Microbot Medical (MBOT), Kewaunee Scientific (KEQU), and Hyperfine (HYPR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Inspira Technologies OXY B.H.N. compare to CVRx?

Inspira Technologies OXY B.H.N. (NASDAQ:IINN) and CVRx (NASDAQ:CVRX) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, media sentiment, dividends, risk, institutional ownership and earnings.

Inspira Technologies OXY B.H.N. has higher earnings, but lower revenue than CVRx.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspira Technologies OXY B.H.N.$289K124.39-$13.22MN/AN/A
CVRx$56.65M1.45-$53.31M-$1.98N/A

Inspira Technologies OXY B.H.N. has a beta of 2.16, meaning that its stock price is 116% more volatile than the broader market. Comparatively, CVRx has a beta of 0.81, meaning that its stock price is 19% less volatile than the broader market.

CVRx has a consensus price target of $6.90, indicating a potential upside of 124.03%. Given CVRx's stronger consensus rating and higher probable upside, analysts clearly believe CVRx is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
CVRx
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.33

12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. Comparatively, 75.3% of CVRx shares are held by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are held by insiders. Comparatively, 16.6% of CVRx shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to CVRx's net margin of -84.93%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat CVRx's return on equity.

Company Net Margins Return on Equity Return on Assets
Inspira Technologies OXY B.H.N.N/A N/A N/A
CVRx -84.93%-152.35%-50.93%

In the previous week, CVRx had 19 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 19 mentions for CVRx and 0 mentions for Inspira Technologies OXY B.H.N.. CVRx's average media sentiment score of 0.02 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that CVRx is being referred to more favorably in the news media.

Company Overall Sentiment
Inspira Technologies OXY B.H.N. Neutral
CVRx Neutral

Summary

CVRx beats Inspira Technologies OXY B.H.N. on 8 of the 15 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Avita Medical?

Avita Medical (NASDAQ:RCEL) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, earnings, profitability, media sentiment and valuation.

In the previous week, Avita Medical had 4 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 4 mentions for Avita Medical and 0 mentions for Inspira Technologies OXY B.H.N.. Avita Medical's average media sentiment score of 0.49 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that Avita Medical is being referred to more favorably in the media.

Company Overall Sentiment
Avita Medical Neutral
Inspira Technologies OXY B.H.N. Neutral

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than Avita Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Avita Medical$71.61M3.37-$48.59M-$1.44N/A
Inspira Technologies OXY B.H.N.$289K124.39-$13.22MN/AN/A

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Avita Medical's net margin of -56.96%.

Company Net Margins Return on Equity Return on Assets
Avita Medical-56.96% N/A -78.53%
Inspira Technologies OXY B.H.N. N/A N/A N/A

Avita Medical presently has a consensus target price of $8.25, indicating a potential upside of 5.10%. Given Avita Medical's stronger consensus rating and higher possible upside, research analysts clearly believe Avita Medical is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Avita Medical
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Avita Medical has a beta of 1.86, indicating that its share price is 86% more volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, indicating that its share price is 116% more volatile than the broader market.

27.7% of Avita Medical shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. 2.2% of Avita Medical shares are owned by company insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Avita Medical beats Inspira Technologies OXY B.H.N. on 7 of the 13 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Microbot Medical?

Microbot Medical (NASDAQ:MBOT) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, analyst recommendations, institutional ownership, risk, earnings, valuation and dividends.

16.3% of Microbot Medical shares are held by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. 4.7% of Microbot Medical shares are held by insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Microbot Medical currently has a consensus target price of $6.38, suggesting a potential upside of 311.29%. Given Microbot Medical's stronger consensus rating and higher possible upside, equities analysts plainly believe Microbot Medical is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Microbot Medical
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.80
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Microbot Medical has a beta of 1.06, indicating that its stock price is 6% more volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, indicating that its stock price is 116% more volatile than the broader market.

In the previous week, Microbot Medical had 8 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 8 mentions for Microbot Medical and 0 mentions for Inspira Technologies OXY B.H.N.. Microbot Medical's average media sentiment score of 0.29 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that Microbot Medical is being referred to more favorably in the media.

Company Overall Sentiment
Microbot Medical Neutral
Inspira Technologies OXY B.H.N. Neutral

Microbot Medical has higher earnings, but lower revenue than Inspira Technologies OXY B.H.N..

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microbot MedicalN/AN/A-$13.14M-$0.24N/A
Inspira Technologies OXY B.H.N.$289K124.39-$13.22MN/AN/A

Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Microbot Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Microbot MedicalN/A -21.87% -20.76%
Inspira Technologies OXY B.H.N. N/A N/A N/A

Summary

Microbot Medical beats Inspira Technologies OXY B.H.N. on 8 of the 13 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Kewaunee Scientific?

Inspira Technologies OXY B.H.N. (NASDAQ:IINN) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, media sentiment, institutional ownership and earnings.

Kewaunee Scientific has higher revenue and earnings than Inspira Technologies OXY B.H.N..

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspira Technologies OXY B.H.N.$289K124.39-$13.22MN/AN/A
Kewaunee Scientific$282M0.37$9.62M$3.2211.34

In the previous week, Kewaunee Scientific had 1 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 1 mentions for Kewaunee Scientific and 0 mentions for Inspira Technologies OXY B.H.N.. Kewaunee Scientific's average media sentiment score of 0.93 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that Kewaunee Scientific is being referred to more favorably in the news media.

Company Overall Sentiment
Inspira Technologies OXY B.H.N. Neutral
Kewaunee Scientific Positive

12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are owned by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are owned by insiders. Comparatively, 14.1% of Kewaunee Scientific shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Inspira Technologies OXY B.H.N. has a beta of 2.16, meaning that its share price is 116% more volatile than the broader market. Comparatively, Kewaunee Scientific has a beta of 0.72, meaning that its share price is 28% less volatile than the broader market.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Kewaunee Scientific
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Kewaunee Scientific has a net margin of 3.41% compared to Inspira Technologies OXY B.H.N.'s net margin of 0.00%. Kewaunee Scientific's return on equity of 14.10% beat Inspira Technologies OXY B.H.N.'s return on equity.

Company Net Margins Return on Equity Return on Assets
Inspira Technologies OXY B.H.N.N/A N/A N/A
Kewaunee Scientific 3.41%14.10%5.55%

Summary

Kewaunee Scientific beats Inspira Technologies OXY B.H.N. on 9 of the 12 factors compared between the two stocks.

How does Inspira Technologies OXY B.H.N. compare to Hyperfine?

Inspira Technologies OXY B.H.N. (NASDAQ:IINN) and Hyperfine (NASDAQ:HYPR) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, media sentiment, institutional ownership and valuation.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Hyperfine's net margin of -210.75%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Hyperfine's return on equity.

Company Net Margins Return on Equity Return on Assets
Inspira Technologies OXY B.H.N.N/A N/A N/A
Hyperfine -210.75%-97.88%-61.81%

12.7% of Inspira Technologies OXY B.H.N. shares are owned by institutional investors. Comparatively, 15.0% of Hyperfine shares are owned by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are owned by company insiders. Comparatively, 26.3% of Hyperfine shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Hyperfine has a consensus price target of $1.74, indicating a potential upside of 94.59%. Given Hyperfine's stronger consensus rating and higher probable upside, analysts plainly believe Hyperfine is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Hyperfine
1 Sell rating(s)
2 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.33

In the previous week, Hyperfine had 6 more articles in the media than Inspira Technologies OXY B.H.N.. MarketBeat recorded 6 mentions for Hyperfine and 0 mentions for Inspira Technologies OXY B.H.N.. Hyperfine's average media sentiment score of 0.41 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that Hyperfine is being referred to more favorably in the news media.

Company Overall Sentiment
Inspira Technologies OXY B.H.N. Neutral
Hyperfine Neutral

Inspira Technologies OXY B.H.N. has higher earnings, but lower revenue than Hyperfine.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspira Technologies OXY B.H.N.$289K124.39-$13.22MN/AN/A
Hyperfine$11.40M8.31-$35.57M-$0.38N/A

Inspira Technologies OXY B.H.N. has a beta of 2.16, suggesting that its stock price is 116% more volatile than the broader market. Comparatively, Hyperfine has a beta of 1.42, suggesting that its stock price is 42% more volatile than the broader market.

Summary

Inspira Technologies OXY B.H.N. and Hyperfine tied by winning 7 of the 14 factors compared between the two stocks.

Get Inspira Technologies OXY B.H.N. News Delivered to You Automatically

Sign up to receive the latest news and ratings for IINN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IINN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IINN vs. The Competition

Export
MetricInspira Technologies OXY B.H.N.Healthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$35.95M$5.95B$7.06B$13.10B
Dividend YieldN/A1.76%2.57%10.45%
P/E RatioN/A26.22269.0625.28
Price / Sales124.3963.09592.5787.62
Price / CashN/A33.9270.4850.90
Price / Book16.676.1012.916.24
Net Income-$13.22M$148.67M$3.45B$347.60M
7 Day Performance-5.66%1.84%1.12%1.07%
1 Month Performance-32.43%4.56%1.79%1.03%
1 Year Performance-20.32%8.67%67.69%20.77%

Inspira Technologies OXY B.H.N. Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IINN
Inspira Technologies OXY B.H.N.
N/A$1.00
-1.0%		N/A-24.1%$35.95M$289KN/A20
CVRX
CVRx
3.4243 of 5 stars		$5.58
+1.6%		$11.50
+106.1%		-61.9%$145.68M$56.65MN/A160
RCEL
Avita Medical
1.9582 of 5 stars		$4.47
-3.5%		$7.25
+62.2%		+39.1%$142.50M$72.35MN/A130
MBOT
Microbot Medical
2.522 of 5 stars		$1.85
+1.6%		$6.63
+258.1%		-44.7%$122.24MN/AN/A20
KEQU
Kewaunee Scientific
1.2416 of 5 stars		$36.40
+0.3%		N/A-35.3%$104.13M$282M11.301,231

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:IINN) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
Your 10X AI demo is starting…
Keith Kaplan, the AI expert behind tools used by more than 100000 investors, built his models with an investme...
TradeSmith | Sponsoredtc pixel
Ray Dalio: Buy Gold. Get Paid.
Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...
Investors Alley | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Gold buyout deals have handed shareholders overnight gains up to 79 percent
Gold major acquisitions have repriced junior miners overnight, with past deals delivering gains from 40% to 1,...
Golden Portfolio | Sponsoredtc pixel
Who Really Gets Rich from IPOs?
Peter Thiel turned a $500,000 stake in Meta into nearly $1 billion by investing eight years before its IPO. Tr...
Weiss Ratings | Sponsoredtc pixel